Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆
Marco Bandini, Ewan A. Gibb, Andrea Gallina, Daniele Raggi, Laura Marandino, Marco Bianchi, Jeffrey S. Ross, Maurizio Colecchia, Giorgio Gandaglia, Nicola Fossati, Filippo Pederzoli, Roberta Lucianò, Renzo Colombo, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Andrea Necchi
Topics & Concepts
PembrolizumabMedicineCystectomyInterquartile rangeInternal medicineOncologyConfidence intervalNeoadjuvant therapyProportional hazards modelPopulationBladder cancerImmunotherapyCancerBreast cancerEnvironmental healthBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesCancer, Stress, Anesthesia, and Immune Response